コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d conditions and presented with acute severe hypoxemic respiratory failure.
2 Mechanical ventilation was begun for hypoxemic respiratory failure.
3 al fibrosis with decreasing lung volumes and hypoxemic respiratory failure.
4 is established therapy for term infants with hypoxemic respiratory failure.
5 th high hospital mortality for patients with hypoxemic respiratory failure.
6 aled nitric oxide in premature newborns with hypoxemic respiratory failure.
7 ailure patients, and 86% in 57 patients with hypoxemic respiratory failure.
8 (n = 51, 82%) was the main etiology of acute hypoxemic respiratory failure.
9 d nitric oxide in the premature newborn with hypoxemic respiratory failure.
10 nt for intensive care in children with acute hypoxemic respiratory failure.
11 ane oxygenation in term neonates with severe hypoxemic respiratory failure.
12 n clinical outcome in neonatal patients with hypoxemic respiratory failure.
13 tric oxide (NO) in four patients with severe hypoxemic respiratory failure.
14 of ventilator support in children with acute hypoxemic respiratory failure.
15 -aged patients and is associated with severe hypoxemic respiratory failure.
16 o improve oxygenation in children with acute hypoxemic respiratory failure (AHRF), but their roles in
17 s receiving this drug for treatment of acute hypoxemic respiratory failure (AHRF), in order to determ
19 d patients without hypercapnia who had acute hypoxemic respiratory failure and a ratio of the partial
20 r the treatment of large patients with acute hypoxemic respiratory failure and asymmetric lung diseas
22 genation in near-term and term newborns with hypoxemic respiratory failure and persistent pulmonary h
23 support in near-term and term newborns with hypoxemic respiratory failure and persistent pulmonary h
24 brane oxygenation is needed in neonates with hypoxemic respiratory failure and pulmonary hypertension
25 severe end of this spectrum may present with hypoxemic respiratory failure and pulmonary infiltrates,
26 ng noninvasive ventilation for de novo acute hypoxemic respiratory failure, and a high expired tidal
27 nger, required assisted ventilation, and had hypoxemic respiratory failure as defined by an oxygenati
28 y reveals diffuse bilateral infiltrates, and hypoxemic respiratory failure develops despite appropria
30 ng noninvasive ventilation for de novo acute hypoxemic respiratory failure (i.e., not due to exacerba
31 cillatory ventilation for treatment of acute hypoxemic respiratory failure in children with diffuse a
32 e of high mortality rate among patients with hypoxemic respiratory failure in the intervention arm (8
36 s used ECLS for 100 adults with severe acute hypoxemic respiratory failure (n = 94): paO2/FiO2 ratio
38 acute respiratory infection had more severe hypoxemic respiratory failure (PaO2/FIO2: 106 [66, 160]
39 ad undergone abdominal surgery and developed hypoxemic respiratory failure (partial oxygen pressure <
41 admission to the intensive care unit due to hypoxemic respiratory failure requiring mechanical venti
42 tions, was able to support the same level of hypoxemic respiratory failure secondary to acute lung in
43 als but in a higher percent of patients with hypoxemic respiratory failure than reported in these tri
44 distress syndrome (ARDS) is a form of severe hypoxemic respiratory failure that is characterized by i
47 e hospital mortality for patients with acute hypoxemic respiratory failure who failed NPPV was 64%.
48 on, pulmonary hypertension, and severe acute hypoxemic respiratory failure who underwent endotracheal
49 t of eosinophilic lung disease develop acute hypoxemic respiratory failure with a rapid response to t
50 ritical illness syndrome consisting of acute hypoxemic respiratory failure with bilateral pulmonary i
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。